Achieving adequate cyclosporine exposure in liver transplant recipients: A novel strategy for monitoring and dosing using intravenous therapy

Liver Transplantation

Volumn 10, Issue 5, 2004, Pages 686-691

  Lück, Rainer ^a   Böger, Jan ^a   Kuse, Ernst ^a   Klempnauer, Jürgen ^a   Nashan, Björn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE HEPATITIS; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MONITORING; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOPROPHYLAXIS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AREA UNDER CURVE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC;

EID: 19244365687     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20117     Document Type: Article

References (11)

1. 2). Transplantation 2002;73:953-959.
2. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999;68:55-62.
3. max) correlate with freedom from liver graft rejection: Results of a prospective, randomized comparison of Neoral and Sandimmun for liver transplantation (NOF-8). Transplantation 1999;67:1133-1137.
4. International Neoral Renal Transplantation Study Group. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis. Am J Transplant 2002;2:157-166.
5. Mahalati K, Belitsky P, West K, Kiberd B, Faser A, Sketris I, et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study. J Am Soc Nephrol 2001; 12:823-833.
6. Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999;68:1356-1361.
7. Sindhi R, La Via MF, Paulling E, McMichael J, Burckart G, Shaw S, et al. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamycin regimen. Transplantation 2000;15:69:432-436.
8. Canadian Neoral Renal Transplantation Study Group. Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation. Transplantation 2001; 72:1024-1032.
9. Dunn S, Falkenstein K, Cooney G. Neoral C(2) monitoring in pediatric liver transplant recipients. Transplant Proc 2001;33: 3094-3095.
10. Goulet OJ, Revillion Y, Gubler MC, Kassis B, Jan D, Colomb V, et al. Renal function and histomorphology after long-term intravenous administration of cyclosporine for small bowel transplantation in pediatric patients. Transplant Proc 1994;26:1428.
11. Prevot A, Semama DS, Justrabo E, Guignard JP, Escousse A, Gouyon JB. Acute cyclosporine A-induced nephrotoxicity: A rabbit model. Ped Nephrol 2000;14: 70-375.